Longitudinal Study to Assess the Clinical Significance of MSI2 Expression in Chronic Myeloid Leukemia Patients

Publisher： Karger

E-ISSN： 1421-9662|136|1|62-64

ISSN： 0001-5792

Source： Acta Haematologica, Vol.136, Iss.1, 2016-05, pp. : 62-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 15, Iss. 6, 2015-06 ,pp. : 729-735

John Wiley & Sons Inc

Access to resources Recommend Favorite

Changes in Expression of Apoptosis-Related Genes Are Linked to the Molecular Response to Imatinib Treatment in Chronic-Phase Chronic Myeloid Leukemia Patients

By  

Acta Haematologica, Vol. 117, Iss. 2, 2006-11 ,pp. : 83-90

Karger

Access to resources Recommend Favorite

Clinical Significance of C-Reactive Protein in Patients on Hemodialysis: A Longitudinal Study

By  

Nephron Clin Pract, Vol. 100, Iss. 4, 2005-04 ,pp. : c140-c145

Karger

Access to resources Recommend Favorite

Atypical Chronic Myeloid Leukemia in Two Pediatric Patients

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 63, Iss. 1, 2016-01 ,pp. : 156-159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tolerability and efficacy of pegylated interferon‐α‐2a in combination with imatinib for patients with chronic‐phase chronic myeloid leukemia

By  

CANCER, Vol. 119, Iss. 24, 2013-12 ,pp. : 4284-4289

John Wiley & Sons Inc

Access to resources Recommend Favorite